ToreBear said:
meat puppet said:
Torebear: based on what?
Please quote a source that states that the BP parameters have been substantially altered since the study. My understanding is they have not been at least wrt blood parameters. But maybe i have missed something.
I'm not sure I get what your thinking about in regards to parameters. The bio passport is evolving continuously. More modules are added and the knowlegebase of the system has grown. Additionally more and more athletes have been subject to this for most of their career. The blood history is much longer.
Mind you my original contention was not that the Biopassport itself was the only reason doping is harder. There are also extensions of the glowtimes for substances with the urine tests. Wada cooperates with big pharma to insert markers of some kind in new drugs under development. Also AD efforts are better at timing their out of competition tests.
My point was that the conclusions of the Ashenden study about the room that athletes have to blood dope and microdose EPO are still quite valid unless the passport's blood components have been altered since the study. I don't think they have been but if they have, I am very interested to learn how.
It is true that more athletes are part of the BP and many athletes have been part of it for 6-7 more years from the study. This is to be welcomed. A steroid module has been added to the bio passport, yes, but that does not substantially diminish the room to blood dope.
However, the point of the study was to show that the passport in its current setup does not trigger suspicion even in the case of substantial blood manipulation in the order of increasing HBmass by ca. 10%. This "room to play" applies to the new athletes who have entered the BP pool as well as to those athletes who now have a longer history in the pool.
Longer history might help catch abnormal fluctuations, of course. But their abnormality is decided by the current setup of the BP blood passport. And its sensitivity to fluctuations induced by doping is what the study tested. Unless the setup is altered, there is a considerable room to dope without triggering suspicion. How many BP cases leading to bans have there been?
Finally, microdose EPO glowtime is not long, perhaps even shorter than the no testing window during nights. So one has to mess it up if a direct pop for pissing hot occurs.
As for your arguments about better governance, coordination and enactment of antidoping in general I remain agnostic but sceptical. What might indicate things having evolved in this direction? In my understanding it is a stretch to argue for improvement since the publication of the Ashenden study.